PD Neurotechnology is a medical device company with a focus on patient monitoring systems for movement disorders.
PD Neurotechnology has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
PD Neurotechnology's investors include National Bank of Greece, Big Pi Ventures, Crimson International Investment, ONASSIS FOUNDATION, NBG Business Seeds.
PD Neurotechnology is headquartered in London, United Kingdom.
PD Neurotechnology is a medical device company with a focus on patient monitoring systems for movement disorders.
PD Neurotechnology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PD Neurotechnology — Funding & Investors." VCBacked, April 25, 2023, https://www.vcbacked.co/company/pd-neurotechnology. Accessed November 17, 2026.
VCBacked. (2023). PD Neurotechnology — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/pd-neurotechnology
{{cite web |title=PD Neurotechnology — Funding & Investors |url=https://www.vcbacked.co/company/pd-neurotechnology |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at PD Neurotechnology? Request a listing update